Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

CRNXCRNX
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in CRINETICS PHARMACEUTICALS IN

JPMORGAN CHASE & CO holds 1.4M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $50.6M as of 2026-Q2. The position was increased (+3.0% shares). CRNX represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$50.6M

Current Shares

1.4M

Total Value Change

+$36.8M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+3.0%
$50.6M0.0%$37.42
30
2026-Q1
Increased
1.3M
+14.7%
$45.4M0.0%$36.32
33
2025-Q4
Decreased
1.2M
-54.1%
$53.8M0.0%$46.55
0
2025-Q3
Increased
2.5M
+658.4%
$104.9M0.0%$41.65
48
2025-Q2
Increased
331,957
+25.0%
$9.5M0.0%$28.76
34
2025-Q1
Decreased
265,495
-1.5%
$8.9M0.0%$33.54
0
2024-Q4
New
269,543
-
$13.8M0.0%$51.13
39

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used